Large-scale testing (Phase 3)Study completedNCT00147758What this trial is testingWelChol® and Sulfonylurea in Treating Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Daiichi Sankyo 400
Testing effectiveness (Phase 2)Looking for participantsNCT07446855What this trial is testingStudy of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid TumoursWho this might be right forSolid Tumours AstraZeneca 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07360743What this trial is testingImmunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 LevelsWho this might be right forNon Small Cell Lung Cancer (Squamous or Non Squamous) UNICANCER 275
Early research (Phase 1)Active Not RecruitingNCT04188548What this trial is testingLY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial CancerWho this might be right forBreast CancerAdvanced Breast CancerMetastatic Breast Cancer+1 more Eli Lilly and Company 500
Not applicableStudy completedNCT00361010What this trial is testingA Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence EpilepsyWho this might be right forEpilepsyChildhood Absence EpilepsySeizures The Cleveland Clinic 20
Post-approval studies (Phase 4)Study completedNCT00727961What this trial is testingEvaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)Who this might be right forOvarian Neoplasms Merck Sharp & Dohme LLC 58
Testing effectiveness (Phase 2)UnknownNCT05274997What this trial is testingA Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell LymphomaWho this might be right forPeripheral T/NK Cell Lymphoma (R/R PTCL) Shanghai YingLi Pharmaceutical Co. Ltd. 97
Early research (Phase 1)Ended earlyNCT03936959What this trial is testingLY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced CancerWho this might be right forAdvanced Cancer Eli Lilly and Company 10
Large-scale testing (Phase 3)Study completedNCT01787396What this trial is testingPhase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.dWho this might be right forType 2 Diabetes Mellitus LG Life Sciences 433
Testing effectiveness (Phase 2)Study completedNCT04417088What this trial is testingExablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin MonotherapyWho this might be right forRecurrent Glioblastoma InSightec 28
Testing effectiveness (Phase 2)Study completedNCT00398125What this trial is testingMonotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected AdultsWho this might be right forInfection, Human Immunodeficiency VirusHIV-1 Infection GlaxoSmithKline 30
Testing effectiveness (Phase 2)WithdrawnNCT04428268What this trial is testingChloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 PneumoniaWho this might be right forCOVID-19 Pneumonia Hospital Universitario Dr. Jose E. Gonzalez
Post-approval studies (Phase 4)UnknownNCT01565096What this trial is testingEffect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin MonotherapyWho this might be right forDiabetes Mellitus Type II ikfe-CRO GmbH 44
Post-approval studies (Phase 4)Study completedNCT01710839What this trial is testingWidefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein OcclusionWho this might be right forCentral Retinal, Hemi Retinal & Brach Retinal Vein Occlusions Charles C Wykoff, PhD, MD 30
Testing effectiveness (Phase 2)Study completedNCT01234857What this trial is testingRidaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)Who this might be right forBreast Cancer Merck Sharp & Dohme LLC 115
Early research (Phase 1)Looking for participantsNCT07260305What this trial is testingA Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor PatientsWho this might be right forAdvanced or Metastatic Solid Tumors Kangabio AUSTRALIA LTD PTY 57
Testing effectiveness (Phase 2)Looking for participantsNCT07159451What this trial is testingA Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast CancerWho this might be right forBreast Cancer Gustave Roussy, Cancer Campus, Grand Paris 140
Not applicableUnknownNCT01083251What this trial is testingThe Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) InfectionWho this might be right forHepatitis B Virus Ziv Hospital 120
Testing effectiveness (Phase 2)Study completedNCT02738502What this trial is testingPrevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase InhibitorsWho this might be right forMaternal-fetal Infection Transmission ANRS, Emerging Infectious Diseases 91
Testing effectiveness (Phase 2)Looking for participantsNCT07439653What this trial is testingTORL-5-700 in Relapsed/Refractory Non Hodgkin's LymphomaWho this might be right forHistologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma TORL Biotherapeutics, LLC 155